Press Releases Cosmos Health Inc.

Equities

COSM

US2214133058

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-29 pm EDT			5-day change	1st Jan Change
0.7089 ^USD	+9.06%		+34.01%	-49.72%

Mar. 21	Cosmos Health Inc. Commences Development of Cloudscreen 2.0 the New Iteration of Its Next Generation AI Drug Repurposing Platform	CI
Mar. 18	Cosmos Health Inc. Receives Regulatory Approval to Sell Sky Premium Life Products in UAE Nutritional Supplements Market	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cosmos Health : Change in Certifying Accountants - Form 8-K	Apr. 26	PU
Cosmos Health : RELATED PARTY TRANSACTION POLICIES AND PROCEDURES - Form 8-K	Mar. 22	PU
Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets, Expects to Increase FY 2024 Annual Revenue by over $5 Million	Mar. 01	AQ
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company	Feb. 21	AQ
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio	Jan. 19	AQ
Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform, Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders	23-10-12	AQ
Cosmos Health Announces Strategic Collaboration with C.A.PAPAELLINAS Group	23-09-21	AQ
Cosmos Health Starts Stock Buyback Program	23-09-14	AQ
Cosmos Health Inc. - BestGrowthStocks.com issues New Growth Report on Cosmos Health	23-09-14	AQ
Cosmos Health Introduces Guidance, Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026, Recaps Significant Events Reported So Far in 2023	23-09-13	AQ
BestGrowthStocks.com issues New Growth Report on Cosmos Health	23-09-13	AQ
Cosmos Health Reports Q2 2023 Financial Results, Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022, Book Value per Share Exceeds $4.04	23-08-16	AQ
Cosmos Health : Purchase Agreement - Form 8-K	23-05-31	PU
COSMOS HEALTH INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-05-11	AQ
COSMOS HEALTH INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-04-12	AQ
COSMOS HEALTH INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	23-03-06	AQ
COSMOS HEALTH INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-02-07	AQ
Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)	23-02-07	PR
COSMOS HEALTH INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-01-17	AQ
COSMOS HEALTH INC. : Financial Statements and Exhibits (form 8-K)	23-01-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cosmos Health Inc.

Equities

COSM

US2214133058

Press Releases

Filters